Leaked memo reveals federal prosecutors doubt legal viability of efforts to dismantle New York City's congestion pricing program, leading to transfer of case oversight.
Roche reports strong Q1 sales, driven by newer medicines, and confirms FY25 outlook despite challenges in Diagnostics Division.
U.S. renews Iran nuclear talks after deal exit, with controversial figure Michael Anton leading the negotiations.
Leaked memo reveals federal prosecutors doubt legal viability of efforts to dismantle New York City's congestion pricing program, leading to transfer of case oversight.
Roche reports strong Q1 sales, driven by newer medicines, and confirms FY25 outlook despite challenges in Diagnostics Division.
U.S. renews Iran nuclear talks after deal exit, with controversial figure Michael Anton leading the negotiations.